407 related articles for article (PubMed ID: 17373838)
21. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform.
Pan S; Rush J; Peskind ER; Galasko D; Chung K; Quinn J; Jankovic J; Leverenz JB; Zabetian C; Pan C; Wang Y; Oh JH; Gao J; Zhang J; Montine T; Zhang J
J Proteome Res; 2008 Feb; 7(2):720-30. PubMed ID: 18186601
[TBL] [Abstract][Full Text] [Related]
22. Human placental lactogen is a first-trimester maternal serum marker of Down syndrome.
Christiansen M; Sørensen TL; Nørgaard-Pedersen B
Prenat Diagn; 2007 Jan; 27(1):1-5. PubMed ID: 17154235
[TBL] [Abstract][Full Text] [Related]
23. [Screen and identify of differential proteins expressed in the placenta of Down's syndrome].
Yan LY; Sun CJ; Wang X; Chen Y; Zhang WY
Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):161-6. PubMed ID: 21575446
[TBL] [Abstract][Full Text] [Related]
24. Proteomic analysis of bovine conceptus fluids during early pregnancy.
Riding GA; Jones A; Holland MK; Hill JR; Lehnert SA
Proteomics; 2008 Jan; 8(1):160-77. PubMed ID: 18095355
[TBL] [Abstract][Full Text] [Related]
25. Proteomic identification of salivary biomarkers of type-2 diabetes.
Rao PV; Reddy AP; Lu X; Dasari S; Krishnaprasad A; Biggs E; Roberts CT; Nagalla SR
J Proteome Res; 2009 Jan; 8(1):239-45. PubMed ID: 19118452
[TBL] [Abstract][Full Text] [Related]
26. The evolving national birth prevalence of Down syndrome in Taiwan. A study on the impact of second-trimester maternal serum screening.
Jou HJ; Kuo YS; Hsu JJ; Shyu MK; Hsieh TT; Hsieh FJ
Prenat Diagn; 2005 Aug; 25(8):665-70. PubMed ID: 16049991
[TBL] [Abstract][Full Text] [Related]
27. Proteomic analysis of the alteration of protein expression in the placenta of Down syndrome.
Sun CJ; Yan LY; Wang W; Yu S; Wang X; Zhang WY
Chin Med J (Engl); 2011 Nov; 124(22):3738-45. PubMed ID: 22340234
[TBL] [Abstract][Full Text] [Related]
28. A proteomic approach identifies early pregnancy biomarkers for preeclampsia: novel linkages between a predisposition to preeclampsia and cardiovascular disease.
Blumenstein M; McMaster MT; Black MA; Wu S; Prakash R; Cooney J; McCowan LM; Cooper GJ; North RA
Proteomics; 2009 Jun; 9(11):2929-45. PubMed ID: 19444803
[TBL] [Abstract][Full Text] [Related]
29. Proteomic identification of serum biomarkers for head and neck cancer surveillance.
Gourin CG; Zhi W; Adam BL
Laryngoscope; 2009 Jul; 119(7):1291-302. PubMed ID: 19444892
[TBL] [Abstract][Full Text] [Related]
30. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling.
Ehmann M; Felix K; Hartmann D; Schnölzer M; Nees M; Vorderwülbecke S; Bogumil R; Büchler MW; Friess H
Pancreas; 2007 Mar; 34(2):205-14. PubMed ID: 17312459
[TBL] [Abstract][Full Text] [Related]
31. Amniotic fluid proteome analysis from Down syndrome pregnancies for biomarker discovery.
Cho CK; Smith CR; Diamandis EP
J Proteome Res; 2010 Jul; 9(7):3574-82. PubMed ID: 20459121
[TBL] [Abstract][Full Text] [Related]
32. Serum leptin in first-trimester Down syndrome pregnancies.
Hedley P; Christiansen M
Prenat Diagn; 2008 Jun; 28(6):475-7. PubMed ID: 18437707
[TBL] [Abstract][Full Text] [Related]
33. A comprehensive characterization of the peptide and protein constituents of human seminal fluid.
Fung KY; Glode LM; Green S; Duncan MW
Prostate; 2004 Oct; 61(2):171-81. PubMed ID: 15305340
[TBL] [Abstract][Full Text] [Related]
34. [Detection of serum biomakers of osteosarcoma by proteomic profiling].
Shen JN; Jin S; Wang J; Huang G; Yin JQ; Guo QC; Li HM; Liu W; Liu SJ; Li MT
Zhonghua Zhong Liu Za Zhi; 2008 Jul; 30(7):519-22. PubMed ID: 19062719
[TBL] [Abstract][Full Text] [Related]
35. An update on antenatal screening for Down's syndrome and specific implications for assisted reproduction pregnancies.
Weisz B; Rodeck CH
Hum Reprod Update; 2006; 12(5):513-8. PubMed ID: 16672245
[TBL] [Abstract][Full Text] [Related]
36. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
Geng X; Wang F; Li YG; Zhu GP; Zhang WM
J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
[TBL] [Abstract][Full Text] [Related]
37. Combining first and second trimester markers for Down syndrome screening: think twice.
Cocciolone R; Brameld K; O'Leary P; Haan E; Muller P; Shand K
Aust N Z J Obstet Gynaecol; 2008 Oct; 48(5):492-500. PubMed ID: 19032666
[TBL] [Abstract][Full Text] [Related]
38. Multidimensional chromatography: a powerful tool for the analysis of membrane proteins in mouse brain.
Lohaus C; Nolte A; Blüggel M; Scheer C; Klose J; Gobom J; Schüler A; Wiebringhaus T; Meyer HE; Marcus K
J Proteome Res; 2007 Jan; 6(1):105-13. PubMed ID: 17203954
[TBL] [Abstract][Full Text] [Related]
39. A label-free nano-liquid chromatography-mass spectrometry approach for quantitative serum peptidomics in Crohn's disease patients.
Nanni P; Levander F; Roda G; Caponi A; James P; Roda A
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3127-36. PubMed ID: 19683480
[TBL] [Abstract][Full Text] [Related]
40. Comparison of different separation technologies for proteome analyses: isoform resolution as a prerequisite for the definition of protein biomarkers on the level of posttranslational modifications.
Hunzinger C; Schrattenholz A; Poznanović S; Schwall GP; Stegmann W
J Chromatogr A; 2006 Aug; 1123(2):170-81. PubMed ID: 16822517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
